The big picture: Developed and executed year-long communications strategy for AbbVie's pre-FDA approved oncology drugs: venetoclax, veliparib, and ABT-414.
Key initiatives:
1. 365-day comprehensive comms plans
2. Disease awareness social campaigns
3. FDA milestone planning
4. Bloomberg Terminal market analysis
5. Medical meeting coverage
2. Disease awareness social campaigns
3. FDA milestone planning
4. Bloomberg Terminal market analysis
5. Medical meeting coverage
By the numbers:
• Featured in top-tier outlets: WSJ, Forbes, Bloomberg
• Generated coverage across 10+ specialized biotech media
• Social campaigns reached millions across lung and breast cancer awareness initiatives
• Generated coverage across 10+ specialized biotech media
• Social campaigns reached millions across lung and breast cancer awareness initiatives
Why it matters: Navigated complex pre-approval communications while building anticipation for breakthrough cancer therapies.
Bottom line: Blended data-driven market analysis with compelling disease awareness storytelling to position AbbVie as an emerging oncology leader.
Select Media Coverage
Sample Media Targets
Media Coverage Analysis
Disease Awareness Tweet Campaigns
